a year ago
BCRX
AnalystsStacy KuStacy Ku's Stock Forecasts
AnalystsStacy Ku
Sectors:
Analyst Ranking
Bottom 14%
#4784 out of 5549 analysts
Average Return
-6.31%
Win Rate
45%5 out of 11
Risk vs Reward
Poor
Good
Stacy Ku's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kalvista Pharmaceuticals IncKALV | +79.79% | $8.76 | $15.75 | 2025-01-07 - 2026-01-06 | Strong Buy |
Centessa Pharmaceuticals PLCCNTA | +31.00% | $17.32 | $22.69 | 2025-01-07 - 2026-01-07 | Strong Buy |
Biocryst Pharmaceuticals IncBCRX | +18.21% | $6.81 | $8.05 | 2025-10-15 - 2026-10-14 | Strong Buy |
Lenz Therapeutics IncLENZ | +8.39% | $3.22 | $3.49 | 2026-10-21 - 2026-10-29 | Strong Buy |
Aurinia Pharmaceuticals IncAUPH | +1.83% | $16.90 | $17.21 | 2026-10-21 - 2026-10-29 | Strong Buy |
Stacy Ku Analyst Color
Get additional color on Stacy Ku's coverage of popular stocks
Stacy Ku's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lenz Therapeutics IncLENZ | 2 | Strong Buy | $45.00 | +1,189.40% | Maintains | a day ago |
Aurinia Pharmaceuticals IncAUPH | 1 | Strong Buy | $18.00 | +4.59% | Maintains | 9 days ago |
Tonix Pharmaceuticals Holding CorpTNXP | 1 | Strong Buy | $22.00 | +316.67% | Initiates Coverage On | 6 months ago |
Grace Therapeutics IncGRCE | 1 | Strong Buy | $8.00 | +312.37% | Maintains | 6 months ago |
Supernus Pharmaceuticals IncSUPN | 1 | Strong Buy | $60.00 | N/A | Maintains | a year ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Strong Buy | $30.00 | N/A | Reinstates | a year ago |
Centessa Pharmaceuticals PLCCNTA | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Kalvista Pharmaceuticals IncKALV | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Verrica Pharmaceuticals IncVRCA | 1 | Strong Buy | $100.00 | N/A | Maintains | 2 years ago |
Astria Therapeutics IncATXS | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.